Joined
·
34 Posts
This study is a final key step in the Company's preparations to submit an Investigational New Drug application to the U.S. Food and Drug Administration in the third quarter in order to initiate a Phase I/II human clinical trial this year.
Online Pharmaceutical Community - Executive Mindshare